Search

Your search keyword '"Wuchereria bancrofti immunology"' showing total 226 results

Search Constraints

Start Over You searched for: Descriptor "Wuchereria bancrofti immunology" Remove constraint Descriptor: "Wuchereria bancrofti immunology" Topic filariasis Remove constraint Topic: filariasis
226 results on '"Wuchereria bancrofti immunology"'

Search Results

1. Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections.

2. Characterization of glycan determinants that mediate recognition of the major Wuchereria bancrofti circulating antigen by diagnostic antibodies.

3. Electrochemical immunosensor for differential diagnostic of Wuchereria bancrofti using a synthetic peptide.

4. Seroepidemiology of helminths and the association with severe malaria among infants and young children in Tanzania.

5. Increased IgG antibody responses to excretory/secretory antigens in neonates born from mothers infected with filarial nematodes.

6. Humans from Wuchereria bancrofti endemic area elicit substantial immune response to proteins of the filarial parasite Brugia malayi and its endosymbiont Wolbachia.

7. Helminth infection alters IgE responses to allergens structurally related to parasite proteins.

8. In utero sensitization modulates IgG isotype, IFN-γ and IL-10 responses of neonates in bancroftian filariasis.

9. Filarial antigens mediate apoptosis of human monocytes through Toll-like receptor 4.

10. Immuno-epidemiology of bancroftian filariasis: a 14-year follow-up study in Odisha, India.

11. Evaluation of diagnostic tests for Wuchereria bancrofti infection in Brazilian schoolchildren.

12. Bancroftian filariasis: circulating B-1 cells decreased in microfilaria carriers and correlate with immunoglobulin M levels.

13. Incidental detection of an isolated microfilaria in squash cytology of an oligodendroglioma: the unexpected 'worm' in the pie.

14. Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen.

15. Maternal filarial infection: association of anti-sheath antibody responses with plasma levels of IFN-γ and IL-10.

16. Future prospects and challenges of vaccines against filariasis.

17. Antibody to the filarial antigen Wb123 reflects reduced transmission and decreased exposure in children born following single mass drug administration (MDA).

18. Effects of 5 rounds of mass drug administration with diethylcarbamazine and albendazole on filaria-specific IgG4 titers in urine: 6-year follow-up study in Sri Lanka.

19. Expanded numbers of circulating myeloid dendritic cells in patent human filarial infection reflect lower CCR1 expression.

20. Association between Toll-like receptor 2 (TLR2) polymorphisms and asymptomatic bancroftian filariasis.

21. Molecular characterization of a truncated antigen (Wb14) of SXP-1 of Wuchereria bancrofti from four endemic regions in India.

22. Wuchereria bancrofti: diminished platelet activation in filarial patients.

23. Transplacental transfer of filarial antigens from Wuchereria bancrofti-infected mothers to their offspring.

24. Size and charge antigens of Dirofilaria immitis adult worm for IgG-ELISA diagnosis of bancroftian filariasis.

25. Antigenemia in young children living in Wuchereria bancrofti-endemic areas of Orissa, India.

26. Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa.

27. Immunoepidemiology of Wuchereria bancrofti infection in two East African communities: antibodies to the microfilarial sheath and their role in regulating host microfilaraemia.

28. Sensitivity of the immunochromatographic card test relative to detection of adult Wuchereria bancrofti worms by ultrasound.

29. Immunoepidemiology of Wuchereria bancrofti infection: parasite transmission intensity, filaria-specific antibodies, and host immunity in two East African communities.

30. Filarial parasites induce NK cell activation, type 1 and type 2 cytokine secretion, and subsequent apoptotic cell death.

31. Circulating filarial antigen in serum and hydrocele fluid from individuals living in an endemic area for bancroftian filariasis.

32. Filariasis coexisting with a cold abscess.

33. Monoclonal antibodies generated against excretory/secretory antigens of mammalian stage larvae of the lymphatic filarial parasite Wuchereria bancrofti.

35. A case of exposure to Bancroftian filariasis in a traveller to Thailand.

36. Filarial-specific antibody response in East African bancroftian filariasis: effects of host infection, clinical disease, and filarial endemicity.

37. Circulating fibrosis markers, eosinophil cationic protein and eosinophil protein X in patients with Wuchereria bancrofti infection: association with clinical status.

38. Prenatal T cell immunity to Wuchereria bancrofti and its effect on filarial immunity and infection susceptibility during childhood.

39. Detection of DNA of W. bancrofti in blood samples by QC-PCR-ELISA-based.

40. Maternal filarial-infection status and its consequences on pregnancy and the newborn, in Ragama, Sri Lanka.

41. The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenaemia.

42. [Diagnostic tests: Filaria].

43. Bancroftian filariasis in an endemic area of Brazil: differences between genders during puberty.

44. Tropical pulmonary eosinophilia.

45. Comparison of an immunochromatographic card test with night blood smear examination for detection of Wuchereria bancrofti microfilaria carriers.

46. The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India.

47. A 26-year follow-up of bancroftian filariasis in two communities in north-eastern Tanzania.

48. Circulating filarial antigen in the hydrocele fluid from individuals living in a bancroftian filariasis area - Recife, Brazil: detected by the monoclonal antibody Og4C3-assay.

49. Parasite antigenaemia and IgG4 antibodies to a filarial protease in an endemic human population in India.

50. The prevalences of Wuchereria bancrofti antigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets.

Catalog

Books, media, physical & digital resources